StockData
Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc. (ASMB) stock

ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.39−0.11 (-0.49%)

Close on Nov 18, 2026Market cap $455.87MP/E –Yield –

Assembly Biosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Assembly Biosciences's revenue for the twelve months ending Jun 30, 2026 was $74.85M, up 125.1% year over year. For fiscal 2025 it was $72.30M, up 153.5% from the year before. The highest annual figure on record is $79.11M in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$72.30M+153.5%
FY2024Dec 31, 2024$28.52M+298.2%
FY2023Dec 31, 2023$7.16M–
FY2022Dec 31, 2022$0-100.0%
FY2021Dec 31, 2021$6.25M-92.1%
FY2020Dec 31, 2020$79.11M+395.6%
FY2019Dec 31, 2019$15.96M+7.8%
FY2018Dec 31, 2018$14.80M+64.1%
FY2017Dec 31, 2017$9.02M–
FY2016Dec 31, 2016$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$13.37M+38.9%
Q1 FY2026Mar 31, 2026$8.21M-12.8%
Q4 FY2025Dec 31, 2025$42.47M+477.3%
Q3 FY2025Sep 30, 2025$10.79M+57.6%
Q2 FY2025Jun 30, 2025$9.63M+12.8%
Q1 FY2025Mar 31, 2025$9.42M+62.8%
Q4 FY2024Dec 31, 2024$7.36M+2.7%
Q3 FY2024Sep 30, 2024$6.85M–
Q2 FY2024Jun 30, 2024$8.53M–
Q1 FY2024Mar 31, 2024$5.79M–
Q4 FY2023Dec 31, 2023$7.16M–
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$0-100.0%
Q1 FY2023Mar 31, 2023$0-100.0%
Q4 FY2021Dec 31, 2021$0-100.0%
Q3 FY2021Sep 30, 2021$6.25M+53.2%
Q4 FY2020Dec 31, 2020$1.04M-78.2%
Q3 FY2020Sep 30, 2020$34.61M+718.0%
Q2 FY2020Jun 30, 2020$39.38M+1178.4%
Q1 FY2020Mar 31, 2020$4.08M+5.0%
Q4 FY2019Dec 31, 2019$4.77M+27.6%
Q3 FY2019Sep 30, 2019$4.23M-1.3%
Q2 FY2019Jun 30, 2019$3.08M-4.3%
Q1 FY2019Mar 31, 2019$3.89M+9.0%
Q4 FY2018Dec 31, 2018$3.74M+12.7%
Q3 FY2018Sep 30, 2018$4.29M+61.1%
Q2 FY2018Jun 30, 2018$3.22M+36.4%
Q1 FY2018Mar 31, 2018$3.57M+421.2%
Q4 FY2017Dec 31, 2017$3.32M–
Q3 FY2017Sep 30, 2017$2.66M–
Q2 FY2017Jun 30, 2017$2.36M–
Q1 FY2017Mar 31, 2017$684.00K–

More Assembly Biosciences figures

See a number that looks wrong?